Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Low density lipoprotein receptors deficiency

Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998 2 275-81. [Pg.26]

B.C. Mortimer, D.J. Beveridge, I.J. Martins and T.G. Redgrave, Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apo E-deficient mice, J. Biol. Chem. 270 (1995) 28767-28776. [Pg.311]

Netea MG, Demacker PN, Kullberg BJ, et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 1996 97 1366-1372. [Pg.104]

Wilson J, Grossman M, Wu C, et al. (1992). Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J. Biol. Chem. 267 963-967. [Pg.155]

Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., and Rollins, B. J. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2,275-281... [Pg.52]

Collins, A. R., Meehan, W. P., Kintscher, U., Jackson, S., Wakino, S., Noh, G., Palinski, W., Hsueh, W. A., and Law, R. E. (2001). Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler Thromb. Vase. Biol. 21, 365-371. [Pg.244]

Kwak BR, Veillard N, Pelli G, et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003 107 1033-1039. [Pg.179]

Kozarsky KP, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperiipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994 269 13695-13702. [Pg.47]

Oka K, Pastore L, Kim IH, et al. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation 2001 103 1274-1281. [Pg.49]

Dehydrogenase Deficiency, Biotinidase Deficiency, and Adrenoleukodystrophy. Catabolism of essential amino acid skeletons is discussed in the chapters Phenylketonuria and HMG-CoA Lyase Deficiency. The chapters Inborn Errors of Urea Synthesis and Neonatal Hyperbilirubinemia discuss the detoxification and excretion of amino acid nitrogen and of heme. The chapter Gaucher Disease provides an illustration of the range of catabolic problems that result in lysosomal storage diseases. Several additional chapters deal with key aspects of intracellular transport of enzymes and metabolic intermediates the targeting of enzymes to lysosomes (I-Cell Disease), receptor-mediated endocytosis (Low-Density Lipoprotein Receptors and Familial Hypercholesterolemia) and the role of ABC transporters in export of cholesterol from the cell (Tangier disease). [Pg.382]

Igbavboa U, Avdulov NA, Chochina SV, Wood WG. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins, f Neurochem. 1997 69 1661-1667. [Pg.242]

The role of NFkB has been reviewed in ref. 205. NFkB is a key regulator of inflammation, immune responses, cell survival, and cell proliferation inhibition of the NFkB pathway in macrophages leads to more severe atherosclerosis in low density lipoprotein receptor (LDLR) deficient mice, possibly by affecting the pro- and anti-inflammatory balance that controls the development of atherosclerosis (reduced production of LPS-stimulated TNF, and reduction in IL-10) (206). [Pg.117]

Furbee JW Jr, Sawyer JK, Parks JS. Lecithin.cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice. J Biol Chem 2002 277 3511-3519. [Pg.177]

P18. Pittman, R. C., Carew, T. E., Attie, A. D., Witztum, J. L., Watanabe, Y., and Steinberg, D., Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J. Biol. Chem. 257, 7994-8000 (1982). [Pg.289]


See other pages where Low density lipoprotein receptors deficiency is mentioned: [Pg.234]    [Pg.104]    [Pg.57]    [Pg.235]    [Pg.269]    [Pg.242]    [Pg.247]    [Pg.234]    [Pg.104]    [Pg.57]    [Pg.235]    [Pg.269]    [Pg.242]    [Pg.247]    [Pg.206]    [Pg.341]    [Pg.111]    [Pg.501]    [Pg.347]    [Pg.9]    [Pg.198]    [Pg.7]    [Pg.5]    [Pg.714]    [Pg.313]    [Pg.262]    [Pg.352]    [Pg.714]    [Pg.217]    [Pg.207]    [Pg.387]    [Pg.205]    [Pg.603]    [Pg.312]   
See also in sourсe #XX -- [ Pg.86 , Pg.87 ]




SEARCH



Lipoprotein receptors

Lipoproteins density

Low density lipoprotein

Low receptor

Receptor density

© 2024 chempedia.info